News

Published on 23 Aug 2022 on Simply Wall St. via Yahoo Finance

Are Alliance Pharma plc's (LON:APH) Mixed Financials Driving The Negative Sentiment?


Article preview image

Alliance Pharma (LON:APH) has had a rough three months with its share price down 19%. It seems that the market might have completely ignored the positive aspects of the company's fundamentals and decided to weigh-in more on the negative aspects. Long-term fundamentals are usually what drive market outcomes, so it's worth paying close attention. Particularly, we will be paying attention to Alliance Pharma's ROE today.

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. Put another way, it reveals the company's success at turning shareholder investments into profits.

See our latest analysis for Alliance Pharma

LSE.APH price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Amphenol's (APH) Q4 Earnings Beat Estimates, Revenues Rise Y/Y

Amphenol’s APH fourth-quarter 2022 adjusted earnings of 78 cents per share beat the Zacks Consens...

Zacks via Yahoo Finance 25 Jan 2023

Amphenol (APH) to Report Q4 Earnings: What's in the Cards?

Amphenol APH is set to report fourth-quarter 2022 results on Jan 25, 2023.Amphenol expects fourth...

Zacks via Yahoo Finance 20 Jan 2023

Is Alliance Pharma plc (LON:APH) Trading At A 49% Discount?

Today we will run through one way of estimating the intrinsic value of Alliance Pharma plc (LON:A...

Simply Wall St. via Yahoo Finance 18 Jan 2023

Amphenol Communications Solutions releases Internal High-Speed Link Input Output Connectors...

In Close Collaboration with PCI-SIG, the Leading Supplier to Enterprise Server Solution Providers...

WAFB Baton Rouge 27 Dec 2022

Is Amphenol Corporation (NYSE:APH) Expensive For A Reason? A Look At Its Intrinsic Value

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of ...

Simply Wall St. via Yahoo Finance 25 Dec 2022

Amphenol: Strong Fundamentals, But Wait For A Pullback (NYSE:APH)

Amphenol Corporation (NYSE:APH) has been exceeding expectations in recent quarters, with its last...

Seeking Alpha 25 Dec 2022

Amphenol: Enabling The Electronics Revolution (NYSE:APH)

The company has been and is an enabler of the electronic revolution worldwide and has executed...

Seeking Alpha 24 Dec 2022

Alliance Pharma plc (LON:APH) is a favorite amongst institutional investors who own 85%

Every investor in Alliance Pharma plc (LON:APH) should be aware of the most powerful shareholder ...

Simply Wall St. via Yahoo Finance 2 Dec 2022

Amphenol (NYSE:APH) Is Paying Out A Larger Dividend Than Last Year

Amphenol Corporation (NYSE:APH) will increase its dividend from last year's comparable payment on...

Simply Wall St. via Yahoo Finance 29 Oct 2022

10 Best Pharma Dividend Stocks To Buy

In this article, we discuss 10 best pharma dividend stocks to buy. If you want to see more stocks...

Insider Monkey via Yahoo Finance 28 Oct 2022